Colin J. Meyer
2019
In 2019, Colin J. Meyer earned a total compensation of $2.2M as Chief Medical Officer and Executive Vice President, Product Development at REATA PHARMACEUTICALS, a 249% increase compared to previous year.
Compensation breakdown
| Bonus | $389,467 |
|---|---|
| Option Awards | $1,347,713 |
| Salary | $445,600 |
| Total | $2,182,780 |
Meyer received $1.3M in option awards, accounting for 62% of the total pay in 2019.
Meyer also received $389.5K in bonus and $445.6K in salary.
Rankings
In 2019, Colin J. Meyer's compensation ranked 5,477th out of 13,971 executives tracked by ExecPay. In other words, Meyer earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,477 out of 13,971 | 61st |
Division Manufacturing | 2,043 out of 5,701 | 64th |
Major group Chemicals And Allied Products | 725 out of 2,200 | 67th |
Industry group Drugs | 609 out of 1,886 | 68th |
Industry Pharmaceutical Preparations | 449 out of 1,398 | 68th |
Source: SEC filing on April 29, 2020.
Meyer's colleagues
We found five more compensation records of executives who worked with Colin J. Meyer at REATA PHARMACEUTICALS in 2019.
2019
Manmeet Soni
REATA PHARMACEUTICALS
Chief Financial Officer
2019
J Huff
REATA PHARMACEUTICALS
Chief Executive Officer
2019
Jason Wilson
REATA PHARMACEUTICALS
Executive Vice President, Operations
2019
Michael Wortley
REATA PHARMACEUTICALS
Chief Legal Officer
2019
Dawn Bir
REATA PHARMACEUTICALS
Chief Commercial Officer and Executive Vice President
News
REATA PHARMACEUTICALS CEO J Huff's 2021 pay falls 37% to $4M
April 29, 2022
REATA PHARMACEUTICALS CEO J Huff's 2020 pay rises 15% to $6.4M
April 30, 2021
REATA PHARMACEUTICALS CFO Manmeet Soni receives $13M in 2019
April 29, 2020
REATA PHARMACEUTICALS CEO J Huff's 2018 pay falls 82% to $935K
April 30, 2019